NCT06612632View on ClinicalTrials.gov

Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 24, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2028

Conditions
Cancer
Interventions
DRUG

research drug in combination with Toripalimab

research drug in combination with Toripalimab

DRUG

Toripalimab

Toripalimab

Trial Locations (1)

Unknown

RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER